Cargando…
Evaluation of the effect of 100U of Onabotulinum toxin A on detrusor contractility in women with idiopathic OAB: A multicentre prospective study
AIMS: Intradetrusor injection of Onabotulinum Toxin A (BTX‐A) is a third‐line treatment for overactive bladder (OAB). Voiding dysfunction and the need for intermittent catheterization are potential complications, consequent to bladder contractility (BC) decrement. Primary aim: to evaluate BC variati...
Autores principales: | De Rienzo, Gaetano, Minafra, Paolo, Iliano, Ester, Agrò, Enrico Finazzi, Serati, Maurizio, Giammò, Alessandro, Bianchi, Francesco Paolo, Costantini, Elisabetta, Ditonno, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297902/ https://www.ncbi.nlm.nih.gov/pubmed/34664738 http://dx.doi.org/10.1002/nau.24820 |
Ejemplares similares
-
OAB score: A clinical model that predicts the probability of presenting overactive detrusor in the urodynamic study
por: Arribillaga, Leandro Cristian, et al.
Publicado: (2018) -
Real-Time Documentation of the Effect of Onabotulinumtoxin A Detrusor Injection in OAB Patients—Preliminary Results
por: Schulte-Baukloh, Heinrich, et al.
Publicado: (2022) -
The Role of Apoptosis in Detrusor Contractility
por: Kim, Su Jin
Publicado: (2020) -
Intradetrusor Injections of Onabotulinum Toxin-A in Children With Urinary Incontinence due to Neurogenic Detrusor Overactivity Refractory to Antimuscarinic Treatment
por: Tarcan, Tufan, et al.
Publicado: (2014) -
Percutaneous tibial nerve stimulation in the treatment of neurogenic
detrusor overactivity in multiple sclerosis patients: a historically controlled
study
por: Carilli, Marco, et al.
Publicado: (2023)